Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients. The funding will advance the Company’s clinical and development programs, including the ongoing FASTR trial and its upcoming pivotal trial.
Who to call at Reprieve Cardiovascular, and when
A new round usually means Reprieve Cardiovascular is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Reprieve Cardiovascular raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Reprieve Cardiovascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Reprieve Cardiovascular. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Reprieve Cardiovascular
Location
459 Fortune Boulevard
Milford, Massachusetts, United States
About
Reprieve Cardiovascular Inc. is a startup focusing on developing an intelligent fluid management system for acute decompensated heart failure. Their technology aims to reduce the high rate of readmissions for heart failure patients by providing personalized diuretic dosing and fluid replacement.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Reprieve Cardiovascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MilfordHealthcareHealth Care